MetLife, Inc.

MET Financial Services · Insurance - Life
Delayed 15 min
Last close
$100.27
Oct 16, 2026
52-week range
$67.33 — $101.44
-1% from high
Market cap
63.7B
Diluted basis
Dividend yield
2.4%
P/E
19.3
Trailing
Verdict status · Oct 16, 2026

Not yet scored

Filing.fyi has not computed forensic scores for MET yet. Scores appear after the company's next data refresh.

No verdict yet
RED DEEP Scores pending shown after the next data refresh
Composite Health
AI synthesis · written from this company's SEC filings · not investment advice

What the filing actually says.

AI · forensic preset

The filings show an operating line that is steadier than the bottom line. Operating income of $6.14 billion in 2025 was modestly above $6.00 billion in 2024 and $5.72 billion in 2023, but net income moved the other way, falling to $3.38 billion from $4.43 billion. Net income was $1.58 billion in 2023, so the 2025 figure sits between that low and the 2024 level. Readers may want to look at the notes to the financial statements for the items that explain the difference, because the excerpts provided do not include that reconciliation. Management's narrative centers on the New Frontier strategy and the Strategic Reorganization. The company says it intends to extend its leadership in Group Benefits, capitalize on its retirement platform, accelerate growth in asset management through MetLife Investment Management, and expand in high-growth international markets across Asia, Latin America and EMEA. These are strategic statements, and the excerpts do not include segment-level results that would test them. The reorganization also moved certain products out of MetLife Holdings into Group Benefits and RIS. That change was applied only to 2025, so readers may want to compare segment results across years with that in mind. The Item 3 market risk disclosure states that the fair values of certain assets and liabilities are materially exposed to interest rates, foreign currency exchange rates and equity markets, with no material changes from the 2025 Annual Report. The Item 4 conclusion is that disclosure controls were effective and internal control over financial reporting had no material changes in the first quarter of 2026. Legal matters are cross-referenced to Note 18 of the interim statements, which is not part of the excerpt. Capital return is also a constraint: the 10-Q points to a risk factor stating that the ability to pay dividends or repurchase stock depends on legal, regulatory and cash buffer requirements, so buyback capacity is not unlimited.

Catalyst.According to the 2025 10-K, MetLife reorganized in the fourth quarter of 2025 around its New Frontier strategy, which prioritizes Group Benefits, retirement, asset management and high-growth international markets. The reorganization made MetLife Investment Management a reportable segment, producing six segments: Group Benefits, RIS, Asia, Latin America, EMEA and MIM. Reported revenues rose from $2.25 billion in 2024 to $2.44 billion in 2025, about 8% higher, and operating income edged up from $6.00 billion to $6.14 billion. In the first quarter of 2026 the company repurchased 10,121,118 shares and had $1.3 billion of its April 2025 authorization remaining at March 31, 2026.

Hidden risk.The main tension is between operating income and net income. Net income fell from $4.43 billion in 2024 to $3.38 billion in 2025, a drop of about 24%, even though operating income rose about 2%. Net income equaled about 55% of operating income in 2025, compared with about 74% in 2024, so the gap between the two measures widened. Readers may want to examine the items that bridge them. The 2026 10-Q states there are no material changes to risk factors, so the 10-K list still applies, including reinsurance counterparty risk, credit rating downgrades, closed block deficiencies and the Brighthouse separation. The revenue and income figures in this data set also appear to be at a scale that should be checked against the audited statements.

Market signals · from trading data, not filings

What traders are betting.

The scores above come from what MET reports to the SEC. These readings come from how traders are positioned in its shares. They change quickly, they can be wrong, and they are not part of the verdict.
Short interest Shares sold short · reported twice a month
1.8%
of the shares available to trade
Low
0%5% · 10% · 20%25%+

The metric

Shares that traders have borrowed and sold, betting the price will fall, and not yet bought back. Brokers report the total to FINRA twice a month. Days to cover divides it by the shares that change hands on a typical day.

Shares sold short
11.2M
Change since Aug 31
−5.5%
Days to cover
3.6

What it tells us

Few traders are betting against MET. Levels this low are common for large, widely held companies.

Little changed since the Aug 31 report (−5.5%).

At normal trading volume, short sellers would need about 3.6 days to buy back every borrowed share.

How investors use it

  • Squeeze watching. Some aggressive traders seek out heavily shorted stocks, betting that good news will force short sellers to buy back shares and push the price higher.
  • Hedging. Funds short one company to offset risk in another, often owning a stronger business and shorting a weaker one in the same industry.
  • Timing. Chart-based traders pair rising short interest with price patterns, such as a break below a level where buyers used to step in, to decide when to enter or exit.
  • Warning sign. Some owners treat a sharp rise in short interest as a red flag and respond by tightening stop-loss orders or holding smaller positions.

Lesson: short interest, explained →

Short-interest report for Sep 30, 2026, via Yahoo Finance. Reports come out about a week and a half after that date.

SEC filings · last 12 months

Annual report, quarterly reports & proxy statement

The annual report (10-K), quarterly reports (10-Q), proxy statement (DEF 14A) and current reports (8-K) MetLife filed in the last 12 months, each linked to the original document on SEC EDGAR.

  • Sep 24, 2026
    8-K
    Current reportItem 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Aug 17, 2026
    8-K
    Current reportItem 8.01: Other events0
    EDGAR →
  • Aug 6, 2026
    10-Q
    Quarterly report0
    EDGAR →
  • Aug 5, 2026
    8-K
    Current reportItem 2.02: Results of operations (earnings); Item 7.01: Regulation FD disclosure (investor materials); Item 8.01: Other events0
    EDGAR →
  • May 7, 2026
    10-Q
    Quarterly report (2026-03-31)Period: 2026-03-310
    EDGAR →
  • May 6, 2026
    8-K
    Current report (2026-05-06)Item 2.02: Results of operations (earnings); Item 7.01: Regulation FD disclosure (investor materials); Item 8.01: Other events0
    EDGAR →
  • Apr 29, 2026
    DEF 14A
    Proxy statement (2026-06-16)0
    EDGAR →
  • Apr 7, 2026
    8-K
    Current report (2026-04-07)Item 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Mar 5, 2026
    8-K
    Current report (2026-03-05)Item 8.01: Other events0
    EDGAR →
  • Feb 19, 2026
    10-K
    Annual report (2025-12-31)Period: 2025-12-310
    EDGAR →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →